Endovascular Treatment With Versus Without Intravenous Tenecteplase in Stroke
Status:
Not yet recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate whether intravenous tenecteplase prior to
endovascular treatment can improve 90-day functional outcome of stroke patients with large
vessel occlusion who are thrombolysis-eligible within 4.5 hours of symptom onset.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Xinqiao Hospital of Chongqing
Collaborators:
Maoming Traditional Chinese Medicine Hospital (Wenguo Huang) The 904th Hospital of PLA (Zhonghua Shi) The First Affiliated Hospital of Jilin University (Shouchun Wang) Wuhan No. 1 Hospital (Wenhua Liu)